Johnson & Johnson Innovation Plans Research Center In New York City
01/09/2017
The 30,000-square foot facility will be located at the New York Genome Center in the SoHo section of Manhattan and open in 2018. As an incentive, the project is receiving $17 million in New York State funding. The site will be open to biotech, pharmaceutical, medical device and consumer health companies, particularly startups working on cross-sector solutions to prevent, intercept or cure diseases.
"Expanding the JLABS model to New York City, home to world-class academic and medical institutions, furthers Johnson & Johnson Innovation's commitment to providing resources that catalyze and foster the growth of life science ecosystems around the world," said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson. "Our hope is that JLABS @ NYC will provide a resource-rich environment for innovators throughout the New York region where today's ideas can become healthcare products that truly impact patient's lives."
JLABS, in addition to offering emerging life science companies modular lab units, office space, shared core laboratory equipment and business facilities, will link the entrepreneurs of New York with the full breadth of Johnson & Johnson Innovation, including opportunities for funding, third-party services, educational events and R&D experts from medical technology, consumer healthcare product and Janssen pharmaceutical teams.
"The ever-evolving life science sector is discovering solutions to the most pressing problems of our time, helping to cure disease and save lives around the world," said Governor Andrew Cuomo. "New York is poised to be a global leader in this industry, and the new, vital incubator JLABS will be the catalyst that pushes our state into the forefront of this exciting field.”
"The New York Genome Center is excited to be a partner with Johnson & Johnson Innovation, Governor Cuomo and New York State in bringing JLABS to New York," said NYGC President & COO Cheryl A. Moore. "JLABS' support of talented scientists in New York as they take their innovative ideas to market aligns with our mission of fostering intellectually vibrant collaborations that advance the development of new treatments, therapies and therapeutics against human disease."
Project Announcements
Samsung Electronics Expands Taylor, Texas, Chip-Manufacturing Operations
04/18/2024
OMCO Solar Plans Huntsville, Alabama, Production Operations
04/18/2024
Martco-RoyOMartin Upgrades Allen Parish, Louisiana, Operations
04/18/2024
Estes Energetics Expands Bossier Parish, Louisiana, Production Operations
04/18/2024
BENTELER Steel/Tube Manufacturing Expands Port of Caddo-Bossier, Louisiana, Operations
04/18/2024
Washington Penn Plastic Establishes Winchester, Kentucky, Production Operations
04/18/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024